The role of marine omega‐3 (n‐3) fatty acids in inflammatory processes, atherosclerosis and plaque stability
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Atherosclerosis has an important inflammatory component and acute cardiovascular events can be initiated by inflammatory processes occurring in advanced plaques. Fatty acids influence inflammation through a variety of mechanisms; many of these are mediated by, or associated with, the fatty acid composition of cell membranes. Human inflammatory cells are typically rich in the n-6 fatty acid arachidonic acid, but the contents of arachidonic acid and of the marine n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can be altered through oral administration of EPA and DHA. Eicosanoids produced from arachidonic acid have roles in inflammation. EPA also gives rise to eicosanoids and these are usually biologically weak. EPA and DHA give rise to resolvins which are anti-inflammatory and inflammation resolving. EPA and DHA also affect production of peptide mediators of inflammation (adhesion molecules, cytokines, etc.). Thus, the fatty acid composition of human inflammatory cells influences their function; the contents of arachidonic acid, EPA and DHA appear to be especially important. The anti-inflammatory effects of marine n-3 polyunsaturated fatty acids (PUFAs) may contribute to their protective actions towards atherosclerosis and plaque rupture.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Omega-3 fatty acids are integrated into biological membranes including those in the atherosclerotic plaque where they influence signal transduction pathways involved in atherogenesis (Calder, 2012;Mozaffarian and Wu, 2011).”
From Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction (2018) · cites this paper as Calder, 2012
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051 · cited 3×
“Mice deficient in the adhesion molecules intercellular adhesion molecule 1 (ICAM1), E-selectin or P-selectin show less atherosclerosis when fed an atherosclerotic diet [1,3], indicating the importance of endothelial-leukocyte adhesive interactions in the atherosclerotic process.”
BackgroundResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Self-citationYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · cited 1×
“Serum interleukin (IL)-6 concentrations may also be predictive [9].”
BackgroundEndres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Hwang, S.-J., Ballantyne, C. M., Sharrett, A. R., Smith, L. C., Davis, C. E., Gotto, A. M., & Boerwinkle, E. (1997) · Circulation · doi:10.1161/01.cir.96.12.4219 · Cited by 1,344 · cited 1×
“sICAM-1 concentration was shown to be an independent predictor of coronary heart disease [7,8].”
BackgroundLee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229 · cited 1×
“sICAM-1 concentration was shown to be an independent predictor of coronary heart disease [7,8].”
BackgroundLewis (1990) · doi:10.1056/nejm199009063231006 · Cited by 1,200 · cited 1×
“These are long recognised mediators and regulators of inflammation and immunity and include prostaglandins (PG), thromboxanes, leukotrienes (LT) and other oxidised derivatives produced by the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 pathways [23, 24].”
BackgroundSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146 · cited 1×
“Marine n-3 PUFAs have been demonstrated to reduce the risks of cardiovascular events and mortality [61–66], including sudden cardiac death [63, 67].”
BackgroundFish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920
Caughey, G., Mantzioris, E., Gibson, R., Cleland, L., & James, M. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.116 · Cited by 860
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Thies, F., Garry, J. M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C. P., Gallagher, P. J., Calder, P. C., & Grimble, R. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12468-3 · Cited by 739 · cited 2×
“[70] and OCEAN [71], replicated in an animal model [65], are clinically relevant.”
BackgroundMixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725 · cited 1×
“These are long recognised mediators and regulators of inflammation and immunity and include prostaglandins (PG), thromboxanes, leukotrienes (LT) and other oxidised derivatives produced by the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 pathways [23, 24].”
BackgroundPolyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Calder, P. C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.008 · Cited by 721 · cited 2×
“In general arachidonic acid-derived eicosanoids act in a pro-inflammatory way, although this is an oversimplification since it is now recognised that PGE2, for example, has both pro- and antiinflammatory effects, and that another eicosanoid lipoxin A4 is anti-inflammatory [25].”
BackgroundSelf-citationMeydani, S. N., Endres, S., Woods, M. M., Goldin, B. R., Soo, C., Morrill-Labrode, A., Dinarello, C. A., & Gorbach, S. L. (1991) · The Journal of Nutrition · doi:10.1093/jn/121.4.547 · Cited by 683 · cited 1×
“Several studies in healthy human volunteers involving supplementation of the diet with marine n-3 PUFAs have demonstrated decreased production of TNF- , IL-1 , IL-6 and various growth factors by LPS-stimulated monocytes or mononuclear cells (a mixture of lymphocytes and monocytes) [12, 14, 30, 59, 60].”
BackgroundSoluble P-Selectin and the Risk of Future Cardiovascular Events
Ridker, P. M., Buring, J. E., & Rifai, N. (2001) · Circulation · doi:10.1161/01.cir.103.4.491 · Cited by 564 · cited 2×
“Soluble P-selectin was identified as an independent predictor of future CVD risk in the Women’s Health Study [6]. sICAM-1 concentration was shown to be an independent predictor of coronary heart disease [7,8].”
Backgroundn–3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored
CALDER, P. C. (2004) · Clinical Science · doi:10.1042/cs20040119 · Cited by 560 · cited 1×
“This might explain the significant protective effects of marine n-3 fatty acids towards both fatal and non-fatal cardiovascular events [61–67], which are so far not fully explained [73, 74].”
BackgroundFatty acids and inflammation: The cutting edge between food and pharma
Calder, P. C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.085 · Cited by 516
Cardiovascular effects of marine omega-3 fatty acids
Saravanan, P., Davidson, N. C., Schmidt, E. B., & Calder, P. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60445-x · Cited by 511 · cited 1×
“This might explain the significant protective effects of marine n-3 fatty acids towards both fatal and non-fatal cardiovascular events [61–67], which are so far not fully explained [73, 74].”
BackgroundThe relationship between the fatty acid composition of immune cells and their function
Calder, P. C. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.016 · Cited by 499
De Caterina, R., Cybulsky, M. I., Clinton, S. K., Gimbrone, M. A., & Libby, P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1829 · Cited by 470 · cited 2×
“This has been shown to result in decreased adhesion between leukocytes and endothelial cells [46, 51, 52].”
BackgroundNF-κB inhibition by ω-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription
Novak, T. E., Babcock, T. A., Jho, D. H., Helton, W. S., & Espat, N. J. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00077.2002 · Cited by 409
Eicosapentaenoic Acid Prevents LPS-Induced TNF-α Expression by Preventing NF-κB Activation
Zhao, Y., Joshi-Barve, S., Barve, S., & Chen, L. H. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719345 · Cited by 405
Rees, D., Miles, E. A., Banerjee, T., Wells, S. J., Roynette, C. E., Wahle, K. W., & Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.331 · Cited by 401
Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J., Song, I., Sidhu, R. S., Yuan, C., Warnock, M., Schmaier, A. H., Yokoyama, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703169200 · Cited by 400 · cited 2×
“Usually the EPA-derived mediators are less biologically active than those produced from arachidonic acid [25, 32] or they may even antagonise the action of those produced from arachidonic acid [33].”
BackgroundLemaitre, R. N., King, I. B., Mozaffarian, D., Kuller, L. H., Tracy, R. P., & Siscovick, D. S. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.319 · Cited by 393 · cited 1×
“[70] and OCEAN [71], replicated in an animal model [65], are clinically relevant.”
BackgroundSperling, R. I., Benincaso, A. I., Knoell, C. T., Larkin, J. K., Austen, K. F., & Robinson, D. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116245 · Cited by 349 · cited 1×
“5–1%) and docosahexaenoic acid (DHA) (usually 2–4%) [11–22], although there are differences between the different phospholipid classes in terms of the content of these fatty acids [13].”
BackgroundYaqoob, Pala, Cortina‐Borja, Newsholme, & Calder (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00623.x · Cited by 308 · cited 1×
“This occurs in a dose response fashion [17, 22] and over a period of days [26] to weeks [16, 17, 22], with a new steadystate composition reached within a few weeks.”
BackgroundSelf-citationBilliar, T. R., Bankey, P. E., Svingen, B. A., CURRAN, R. D., West, M. A., Holman, R. T., Simmons, R. L., & Cerra, F. B. (1988) · PubMed · Cited by 243
Cawood, A. L., Ding, R., Napper, F. L., Young, R. H., Williams, J. A., Ward, M. J. A., Gudmundsen, O., Vige, R., Payne, S. P. K., Ye, S., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.022 · Cited by 243
Kew, S., Mesa, M. D., Tricon, S., Buckley, R., Minihane, A. M., & Yaqoob, P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.674 · Cited by 240
Effects of Dietary Lipid Manipulation upon Inflammatory Mediator Production by Murine Macrophages
Yaqoob, P., & Calder, P. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.1106 · Cited by 235
Thies, F., Nebe-von-Caron, G., Powell, J. R., Yaqoob, P., Newsholme, E. A., & Calder, P. C. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.7.1918 · Cited by 232
Trebble, T., Arden, N. K., Stroud, M. A., Wootton, S. A., Burdge, G. C., Miles, E. A., Ballinger, A. B., Thompson, R. L., & Calder, P. C. (2003) · British Journal of Nutrition · doi:10.1079/bjn2003892 · Cited by 228 · cited 1×
“Several studies in healthy human volunteers involving supplementation of the diet with marine n-3 PUFAs have demonstrated decreased production of TNF- , IL-1 , IL-6 and various growth factors by LPS-stimulated monocytes or mononuclear cells (a mixture of lymphocytes and monocytes) [12, 14, 30, 59, 60].”
BackgroundFish Oil Decreases Macrophage Tumor Necrosis Factor Gene Transcription by Altering the NFκB Activity
Lo, C.-J., Chiu, K. C., Fu, M., Lo, R., & Helton, S. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1998.5524 · Cited by 227
Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function
Healy, D. A., Wallace, F. A., Miles, E. A., Calder, P. C., & Newsholme, P. (2000) · Lipids · doi:10.1007/s11745-000-0583-1 · Cited by 227 · cited 1×
“This occurs in a dose response fashion [17, 22] and over a period of days [26] to weeks [16, 17, 22], with a new steadystate composition reached within a few weeks.”
BackgroundSelf-citationRenier, G., Skamene, E., DeSanctis, J., & Radzioch, D. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1515 · Cited by 199
Hughes, D., Pinder, A., Piper, Z., Johnson, I., & Lund, E. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.2.267 · Cited by 191 · cited 1×
“5 g EPA + DHA/day resulted in a lower level of expression of ICAM-1 on the surface of blood monocytes stimulated ex vivo with interferon- [53].”
BackgroundWeber, C., Erl, W., Pietsch, A., Danesch, U., & Weber, P. C. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.622 · Cited by 188
Gibney, M. J., & Hunter, B. J. (1993) · PubMed · Cited by 170
Khalfoun, B., Thibault, F., Watier, H., BARDOS, P., & Lebranchu, Y. (1997) · PubMed · Cited by 170
Matsumoto, M., Sata, M., Fukuda, D., Tanaka, K., Soma, M., Hirata, Y., & Nagai, R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.023 · Cited by 158 · cited 2×
“In separate in vitro studies, EPA attenuated cytokine-induced expression of adhesion molecules by endothelial cells, again confirming earlier studies, and attenuated cytokine-induced expression of MMP-2 and MMP-9 by a macrophage cell line [72].”
ResultControl of endothelial leukocyte adhesion molecules by fatty acids
De Caterina, R., & Libby, P. (1996) · Lipids · doi:10.1007/bf02637052 · Cited by 158 · cited 1×
“This has been shown to result in decreased adhesion between leukocytes and endothelial cells [46, 51, 52].”
BackgroundOmega-3 Fatty Acids and Inflammation: Novel Interactions Reveal a New Step in Neutrophil Recruitment
Tull, S. P., Yates, C. M., Maskrey, B. H., O'Donnell, V. B., Madden, J., Grimble, R. F., Calder, P. C., Nash, G. B., & Rainger, G. E. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000177 · Cited by 154 · cited 1×
“Usually the EPA-derived mediators are less biologically active than those produced from arachidonic acid [25, 32] or they may even antagonise the action of those produced from arachidonic acid [33].”
BackgroundKew, S., Banerjee, T., Minihane, A. M., Finnegan, Y. E., Williams, C. M., & Calder, P. C. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1278 · Cited by 145
Collie-Duguid, E. S. R., & Wahle, K. W. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0516 · Cited by 132
Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations
MILES, E. A., THIES, F., WALLACE, F. A., POWELL, J. R., HURST, T. L., NEWSHOLME, E. A., & CALDER, P. C. (2001) · Clinical Science · doi:10.1042/cs1000091 · Cited by 129 · cited 1×
“1 g EPA + DHA/day decreased circulating levels of soluble VCAM-1 in elderly subjects [54], but it is not clear if this represents decreased surface expression of VCAM-1.”
BackgroundMiles, E. A., Wallace, F., & Calder, P. C. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00446-3 · Cited by 127 · cited 1×
“Indeed, cell culture [46–49] and animal feeding studies [50] have reported decreased expression of some adhesion molecules on the surface of monocytes [49], macrophages [50] or endothelial cells [46–48] following exposure to marine n-3 PUFAs.”
BackgroundHughes, D. A., Southon, S., & Pinder, A. C. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.3.603 · Cited by 126 · cited 1×
“Indeed, cell culture [46–49] and animal feeding studies [50] have reported decreased expression of some adhesion molecules on the surface of monocytes [49], macrophages [50] or endothelial cells [46–48] following exposure to marine n-3 PUFAs.”
BackgroundBabcock, T. A., Novak, T. E., Ong, E., Jho, D. H., Helton, W. S., & Espat, N. J. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6498 · Cited by 125
Baumann, K. H., Hessel, F., Larass, I., Müller, T., Angerer, P., Kiefl, R., & von Schacky, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.59 · Cited by 116 · cited 1×
“Several studies in healthy human volunteers involving supplementation of the diet with marine n-3 PUFAs have demonstrated decreased production of TNF- , IL-1 , IL-6 and various growth factors by LPS-stimulated monocytes or mononuclear cells (a mixture of lymphocytes and monocytes) [12, 14, 30, 59, 60].”
BackgroundAtherosclerotic plaque rupture: emerging insights and opportunities
Plutzky, J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00352-5 · Cited by 112 · cited 2×
“inflammatory event, and the characteristics of an atherosclerotic plaque that make it vulnerable to rupture are a thin fibrous cap and increased numbers of inflammatory cells such as macrophages [4, 5, 68, 69].”
Backgroundn-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo.
von Schacky, C., Kiefl, R., Jendraschak, E., & Kaminski, W. E. (1993) · PubMed · Cited by 102
Faber, J., Berkhout, M., Vos, A. P., Sijben, J., Calder, P. C., Garssen, J., & van Helvoort, A. (2011) · Journal of Nutrition · doi:10.3945/jn.110.132985 · Cited by 99 · cited 1×
“This occurs in a dose response fashion [17, 22] and over a period of days [26] to weeks [16, 17, 22], with a new steadystate composition reached within a few weeks.”
BackgroundMiles, E. A., Banerjee, T., & Calder, P. C. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.11.008 · Cited by 95
Immunology of ischemic vascular disease: plaque to attack
Hallenbeck, J. M., Hansson, G. K., & Becker, K. J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.007 · Cited by 87 · cited 3×
“inflammatory event, and the characteristics of an atherosclerotic plaque that make it vulnerable to rupture are a thin fibrous cap and increased numbers of inflammatory cells such as macrophages [4, 5, 68, 69].”
BackgroundLong-term supplementation with n-3 fatty acids, II: effect on neutrophil and monocyte chemotaxis
Schmidt, E. B., Varming, K., Pedersen, J. O., Lervang, H.-H., Grunnet, N., Jersild, C., & Dyerberg, J. (1992) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519209088790 · Cited by 80
Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males
Schmidt, E. B., Pedersen, J. O., Ekelund, S., Grunnet, N., Jersild, C., & Dyerberg, J. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90009-9 · Cited by 79
Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations
Miles, E. A., Thiès, F., WALLACE, F. A., Powell, J. R., Hurst, T., Newsholme, E. A., & Calder, P. C. (2001) · Clinical Science · doi:10.1042/cs20000198 · Cited by 64
Basic Science for the Clinician 39: NF-κB—Function, Activation, Control, and Consequences
Sigal, L. H. (2006) · JCR: Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000231385.94784.e4 · Cited by 60 · cited 1×
“Adhesion molecule expression on the surface of endothelial cells and leukocytes is promoted by several transcription factors including the prototypical pro-inflammatory transcription factor, nuclear factor kappa B (NF B) [40, 41].”
BackgroundYates, C. M., Tull, S. P., Madden, J., Calder, P. C., Grimble, R. F., Nash, G. B., & Rainger, G. E. (2011) · Journal of Nutrition · doi:10.3945/jn.111.139287 · Cited by 45 · cited 1×
“This has been shown to result in decreased adhesion between leukocytes and endothelial cells [46, 51, 52].”
BackgroundLuostarinen, R., Siegbahn, A., & Saldeen, T. G. P. (1992) · Nutrition Research · doi:10.1016/s0271-5317(05)80184-8 · Cited by 28
Calder, P. C., & Burdge, G. C. (2012) · Elsevier eBooks · doi:10.1533/9780857097934.1 · Cited by 21
Cited by
Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
Rogero, M., & Calder, P. (2018) · Nutrients · doi:10.3390/nu10040432 · Cited by 706
Nutrition and Cardiovascular Health
Casas, R., Castro-Barquero, S., Estruch, R., & Sacanella, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123988 · Cited by 340
Omega-3 Polyunsaturated Fatty Acids: Benefits and Endpoints in Sport
Gammone, M. A., Riccioni, G., Parrinello, G., & D’Orazio, N. (2018) · Nutrients · doi:10.3390/nu11010046 · Cited by 326
“Together, these anti-inflammatory actions may contribute to omega-3 anti-atherogenic effects [63,78], so that fish oil also appears to help prevent and treat atherosclerosis by slowing the development of plaque and blood clots in arteries.”
BackgroundStearoyl-CoA desaturase: rogue or innocent bystander?
Hodson, L., & Fielding, B. A. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.08.002 · Cited by 215
“PUFAs regulate a wide variety of biological functions including important roles in inflammation and immune function [135–137].”
BackgroundRobertson, R., Guihéneuf, F., Bahar, B., Schmid, M., Stengel, D., Fitzgerald, G., Ross, R., & Stanton, C. (2015) · Marine Drugs · doi:10.3390/md13085402 · Cited by 188
Metadata
- Authors
- Calder, P. C.
- Affiliations
- Southampton General Hospital (GB)
- Corresponding author
- Calder, Philip C.
- ORCID
- Calder, Philip C.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2012-07
- Volume
- 56
- Issue
- 7
- Pages
- 1073-1080
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2003825529
- Cited by
- 255
- References
- 76
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 11 · 2021: 14 · 2020: 19 · 2019: 23 · 2018: 23 · 2017: 20 · 2016: 22 · 2015: 21 · 2014: 29 · 2013: 27 · 2012: 4
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Nutrition & Food Research (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Vifor Pharma and Abbott Nutrition
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
- Keywords
- marine omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, atherosclerosis, plaque stability, plaque rupture, inflammation, arachidonic acid, eicosanoids, resolvins, anti-inflammatory activity, polyunsaturated fatty acids, cell membrane fatty acid composition, cytokines, adhesion molecules
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Endothelium, Vascular, Fish Oils, Humans, Fatty Acids, Omega-3, Inflammation Mediators, Atherosclerosis, Functional Food, Plaque, Atherosclerotic, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.